Physician

Yuanbin Chen, MD

According to 2025 Medicare claims, Yuanbin Chen, MD (NPI: 1467627653) practices hematology/oncology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49444-9739. Chen is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 386 traditional Medicare patients, billed 149,986 HCPCS/CPT codes, and received $4,202,453 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,592 prescription claims across 295 beneficiaries totaling $4,982,930 in drug costs, led by Tagrisso (Osimertinib Mesylate). 2023 DME data shows 42 claims. Open Payments data shows 335 records totaling $2,905,131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $961,181 to $4,202,453. Similarly, Part D prescription costs have moved sharply higher in recent years, from $344,053 to $4,982,930. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $5,010 to $903.